Pacira Germany

Pacira Germany is a leading biotechnology company focused on pioneering innovative solutions in gene therapy. With a commitment to addressing prevalent diseases, Pacira Germany leverages a high-capacity gene therapy vector platform to overcome significant challenges in the field. This platform enables the transfer of large and multiple genes with a single vector, ensures highly efficient gene delivery, and supports large-scale manufacturability.

Located at Harburger Schlossstr. 6-12, Hamburg, 21079, DE, and with additional sites including Im Biotechnologiepark 3, Luckenwalde, Brandenburg 14943, DE, Pacira Germany is dedicated to developing transformative treatments for chronic conditions such as osteoarthritis and intervertebral disc degeneration. The company’s work spans across drug development, animal health, musculoskeletal disease, and human medicine, underlining its broad expertise and commitment to advancing healthcare.

Pacira Germany is poised to make significant contributions to the biotechnology landscape. We invite the management team to enhance this profile further by creating a customized and exclusive company showcase and product listing on our platform, ensuring that Pacira Germany's innovative work reaches an even wider audience.